Table 1.
Splicing Component | Alteration to Splicing Component | Outcome | Associated Disease | References |
---|---|---|---|---|
U1 snRNP | ||||
U1 snRNA | Aggregation in post mortem human brain and spinal cord | RNA processing defects | Alzheimer’s disease | [70] |
U1 snRNA | A→C somatic mutation at third position | Use of cryptic 5′SS | Chronic lymphocytic leukemia Hepatocellular carcinoma |
[71] |
U1 snRNA | A→G somatic mutation at third position | Use of cryptic 5′SS | Sonic hedgehog medulloblastoma | [72] |
U1-70K | N40K isoform | Dominant-negative effect affecting the ability to assemble commitment complex | Alzheimer’s disease | [73] |
U1-70K | Alternative exon between exons 7 and 8 | Shorter transcript | Amyotrophic lateral sclerosis-oxidative stress (ALS-Ox) | [74] |
U2AF complex | ||||
U2AF1 | S34F/Y substitution | Promote exon skipping | Myelodysplastic syndrome | [75,76] |
U2AF1 | S34F substitution | Affects pre-mRNA processing of autophagy-related factor 7 | Myelodysplastic syndrome | [77] |
U2AF1 | Q157R substitution | Promote exon skipping | Myelodysplastic syndrome | [78] |
U2AF2 | SNP rs310445 (T→C) | Not specified | Pancreatic cancer | [79] |
U2AF2 | N196K substitution | Stabilization of open conformation; increases RNA-binding affinity | Acute myeloid leukemia | [80] |
U2AF2 | G301D substitution | Decreases RNA-binding affinity | Colon adenocarcinoma Castration-resistant prostate carcinoma |
[80] |
DDX39B/UAP56 | SNP rs2523506 (C→T) | Decreases translation | Multiple sclerosis | [55] |
U2 snRNP | ||||
SF3A1 | SNP rs2074733 (T→C) | Not specified | Pancreatic cancer | [81] |
SF3B1 | K700E substitution | Disrupt branchpoint recognition and induces usage of cryptic 3′SS | Myelodysplastic syndrome-ring sideroblasts | [82] |
SF3B2 | Loss of function variants | Haploinsufficiency | Craniofacial microsomia | [83] |
SF3B4 | Loss of function variants | Haploinsufficiency | Nager syndrome | [84] |